Granted Patent
B2
US 7,186,528 · App. 10/311,491 · Granted Mar 6, 2007
Method for preparing a physiologically active IL-18 polypeptide
Assignee:
SmithKline Beecham Corporation
View Patent ↗
Loading inventors, assignments & file history…
Abstract
A method for producing a physiologically active polypeptide, comprising contacting a precursor polypeptide with an activating enzyme, or co-expressing the polypeptide with an activating protease.
Claims (3)
1. A method for producing an active human IL-18 polypeptide from a human precursor IL-18 polypeptide, said method comprising the steps of:
(i) co-expressing bicistronically a caspase 5 polypeptide consisting of the amino acid sequence of SEQ ID NO:6, with a human precursor IL-18 polypeptide consisting of the amino acid sequence of SEQ ID NO:1; and
(ii) purifying the active human IL-18 polypeptide (SEQ ID NO:3).
Assignments (2)
CHANGE OF NAME
Recorded Mar 10, 2010
From: SMITHKLINE BEECHAM CORPORATION
To: GLAXOSMITHKLINE LLC
Reel/Frame 024055/0203 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Dec 16, 2002
From: JOHANSON, KYUNG O.; KIRKPATRICK, ROBERT B.; SHATZMAN, ALLAN R.; HO, YEN SEN; MCDEVITT, PATRICK
To: SMITHKLINE BEECHAM CORPORATION
Reel/Frame 013834/0087 →
Continuity (4)
Provisional Application
6021183200
· Jun 15, 2000
Provisional Application
6022412800
· Aug 10, 2000
Provisional Application
6026492300
· Jan 30, 2001